Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan

被引:0
|
作者
Goki Suda
Norihiro Furusyo
Hidenori Toyoda
Yoshiiku Kawakami
Hiroki Ikeda
Michihiro Suzuki
Keiko Arataki
Nami Mori
Keiji Tsuji
Yoshio Katamura
Koichi Takaguchi
Toru Ishikawa
Kunihiko Tsuji
Noritomo Shimada
Atsushi Hiraoka
Sho Yamsaki
Masato Nakai
Takuya Sho
Kenichi Morikawa
Koji Ogawa
Mineo Kudo
Atsushi Nagasaka
Ken Furuya
Yoshiya Yamamoto
Kanji Kato
Yoshiyuki Ueno
Etsuko Iio
Yasuhito Tanaka
Masayuki Kurosaki
Takashi Kumada
Kazuaki Chayama
Naoya Sakamoto
机构
[1] Hokkaido University,Department of Gastroenterology and Hepatology, Graduate School of Medicine
[2] Kyushu University Hospital,Department of General Internal Medicine
[3] Ogaki Municipal Hospital,Department of Gastroenterology
[4] Hiroshima University,Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical and Health Science
[5] St. Marianna University School of Medicine,Division of Gastroenterology and Hepatology
[6] Tsuchiya General Hospital,Department of Gastroenterology/Liver Center
[7] Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital,Department of Gastroenterology
[8] Onomichi General Hospital,Department of Hepatology
[9] Kagawa Prefectural Central Hospital,Department of Gastroenterology and Hepatology
[10] Saiseikai Niigata Daini Hospital,Center for Gastroenterology
[11] Teine Keijinkai Hospital,Division of Gastroenterology and Hepatology
[12] Ootakanomori Hospital,Gastroenterology Center
[13] Ehime Prefectural Central Hospital,Department of Gastroenterology and Hepatology
[14] Sapporo Hokuyu Hospital,Department of Gastroenterology, Faculty of Medicine
[15] Sapporo City General Hospital,Department of Gastroenterology and Hepatology
[16] Japan Community Health Care Organization (JCHO) Hokkaido Hospital,undefined
[17] Hakodate City Hospital,undefined
[18] Iwamisawa Manicipal General Hospital,undefined
[19] Yamagata University,undefined
[20] Nagoya City University Graduate School of Medical Sciences,undefined
[21] Musashino Red Cross Hospital,undefined
来源
关键词
Hemodialysis; HCV; DAAs; CKD;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:119 / 128
页数:9
相关论文
共 50 条
  • [31] Study of incidence of hepatitis C virus infection in hemodialysis patients
    Chigurupati, Pragati
    Subbarayudu, S.
    Babu, Sarath
    ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2014, 7 (03) : 167 - 170
  • [32] Incidence rates of hepatitis C virus infection among blood donors in Japan: a nationwide retrospective cohort study
    Uchida, Shigeharu
    Satake, Masahiro
    Kurisu, Akemi
    Sugiyama, Aya
    Ko, Ko
    Akita, Tomoyuki
    Tanaka, Junko
    TRANSFUSION, 2018, 58 (12) : 2880 - 2885
  • [33] Hepatitis C virus infection in hemodialysis patients
    Simon, N
    PATHOLOGIE BIOLOGIE, 1995, 43 (08): : 735 - 740
  • [34] Hepatitis C virus infection in hemodialysis patients
    Vallet-Pichard, Anais
    Pol, Stanislas
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2013, 37 (04) : 340 - 346
  • [35] Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir Combination
    Tamori, Akihiro
    Hai, Hoang
    Uchida-Kobayashi, Sawako
    Enomoto, Masaru
    Kozuka, Ritsuzo
    Motoyama, Hiroyuki
    Kawamura, Etsushi
    Hagihara, Atsushi
    Teranishi, Yuga
    Yoshida, Kanako
    Morikawa, Hiroyasu
    Murakami, Yoshiki
    Kawada, Norifumi
    ANNALS OF HEPATOLOGY, 2017, 16 (05) : 734 - 741
  • [36] The Pharmacokinetics of Daclatasvir and Asunaprevir Administered in Combination in Studies in Healthy Subjects and Patients Infected with Hepatitis C Virus
    Eley, Timothy
    Sevinsky, Heather
    Huang, Shu-Pang
    He, Bing
    Zhu, Kurt
    Kandoussi, Hamza
    Gardiner, David
    Grasela, Dennis M.
    Bertz, Richard
    Bifano, Marc
    CLINICAL DRUG INVESTIGATION, 2014, 34 (09) : 661 - 671
  • [37] Effect and Safety of Daclatasvir-Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b-Infected Patients on Hemodialysis
    Miyazaki, Ryoichi
    Miyagi, Kyoko
    THERAPEUTIC APHERESIS AND DIALYSIS, 2016, 20 (05) : 462 - 467
  • [38] Daclatasvir for the treatment of hepatitis C virus infection
    Adler, Hugh
    Lambert, John S.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 725 - 738
  • [39] The Pharmacokinetics of Daclatasvir and Asunaprevir Administered in Combination in Studies in Healthy Subjects and Patients Infected with Hepatitis C Virus
    Timothy Eley
    Heather Sevinsky
    Shu-Pang Huang
    Bing He
    Kurt Zhu
    Hamza Kandoussi
    David Gardiner
    Dennis M. Grasela
    Richard Bertz
    Marc Bifano
    Clinical Drug Investigation, 2014, 34 : 661 - 671
  • [40] Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapy
    Hayashi, Kazuhiko
    Ishigami, Masatoshi
    Ishizu, Yoji
    Kuzuya, Teiji
    Honda, Takashi
    Hirooka, Yoshiki
    Toyoda, Hidenori
    Kumada, Takashi
    Hattori, Masashi
    Katano, Yoshiaki
    Goto, Hidemi
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (12) : 1446 - 1451